Why Did The Seelos Therapeutics (SEEL) Stock Rise By 5% In Extended Session?
The clinical-stage biopharmaceutical business Seelos Therapeutics Inc (Nasdaq: SEEL) was up 5.17% at $0.692 at the time of our last check in after-hours trading as it prepared to take part in a significant event. What event will SEEL be attending? The 12th Annual LifeSci Partners Corporate Access Event will take place in San Francisco, California …
Why Did The Seelos Therapeutics (SEEL) Stock Rise By 5% In Extended Session? Read More »